🔎 Trials Near Me

Home › Cancro ovarico › South Dakota

Studi clinici su Cancro ovarico nello stato di South Dakota

16 studi su Cancro ovarico cercano partecipanti presso sedi nello stato di South Dakota.

Città nello stato di South Dakota

Testo ufficiale dello studio (inglese)

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

  • Sanford Health, Sioux Falls
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 5 ott 2026 · NCT06915025

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Sanford Cancer Center Oncology Clinic, Sioux Falls
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls
In reclutamentoFase 2
Tutte le età · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT05564377

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Avera Medical Group, Sioux Falls
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06270706

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • Sanford Cancer Center /ID# 274901, Sioux Falls
  • Avera Cancer Institute - Sioux Falls /ID# 276226, Sioux Falls
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 29 set 2026 · NCT06890338

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  • Site 0132 - Avera Cancer Institute, Sioux Falls
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 29 set 2026 · NCT05128825

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  • Avera Cancer Institute - Sioux Falls /ID# 278627, Sioux Falls
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 22 set 2026 · NCT07059845

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Sanford Cancer Center-Sioux Falls, Sioux Falls
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 15 set 2026 · NCT07214779

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

  • Avera Cancer Institute Sioux Falls, Sioux Falls
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 14 set 2026 · NCT06787612

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

  • Site 0112, Sioux Falls
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 12 ago 2026 · NCT07546500

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Sanford Cancer Center Oncology Clinic, Sioux Falls
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls
In reclutamento
Età da 35 a 50 · Donne · Aggiornato il 7 ago 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Avera Cancer Institute-Aberdeen, Aberdeen
  • Avera Cancer Institute - Mitchell, Mitchell
  • Avera Cancer Institute at Pierre, Pierre
  • e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 ago 2026 · NCT06580314

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • Sanford Cancer Center Gynecologic Oncology, Sioux Falls
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT06161025

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Sanford Cancer Center, Sioux Falls
  • Sanford USD Medical Center, Sioux Falls
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT04389632

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Avera Medical Group Gynecologic, Sioux Falls
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 2 lug 2026 · NCT06819007

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

  • Avera Cancer Institute, Sioux Falls
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT05377996

Avera Cancer Sequencing and Analytics Protocol (ASAP)

  • Avera Cancer Institute - Aberdeen, Aberdeen
  • Avera Cancer Institute - Mitchell, Mitchell
  • Avera Cancer Institute - Pierre, Pierre
  • e altri 2
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 mar 2026 · NCT05142033

Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.